These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8761114)
1. [Diagnosing predisposition to tumor development by genetic typing]. Thomas G Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B1-4. PubMed ID: 8761114 [No Abstract] [Full Text] [Related]
2. Mechanisms of carcinogenesis and molecular epidemiology. Vainio H; Husgafvel-Pursiainen K Br J Hosp Med; 1996 Aug 21-Sep 3; 56(4):162-70. PubMed ID: 8872345 [TBL] [Abstract][Full Text] [Related]
3. Commentary: A new dawn for genetic epidemiology? Frayling TM Int J Epidemiol; 2009 Aug; 38(4):975-7. PubMed ID: 19584124 [No Abstract] [Full Text] [Related]
4. Counterpoint: genetic risk feedback for common disease time to test the waters. Thompson PA Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1727-9. PubMed ID: 17855689 [No Abstract] [Full Text] [Related]
5. The predominance of the environment over genes in cancer causation: implications for genetic epidemiology. Le Marchand L Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1037-9. PubMed ID: 15894649 [No Abstract] [Full Text] [Related]
6. Genetic ancestry and molecular epidemiology. Sellers TA Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):499-500. PubMed ID: 15066911 [No Abstract] [Full Text] [Related]
7. Genetic variation in susceptibility as a key parameter in risk assessment and risk communication: policy aspects. Omenn GS Prog Clin Biol Res; 1996; 395():235-47. PubMed ID: 8895993 [No Abstract] [Full Text] [Related]
9. Integrative study designs--next step in the evolution of molecular epidemiology? Caporaso NE Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):365-6. PubMed ID: 17372231 [No Abstract] [Full Text] [Related]
14. Systems epidemiology in cancer. Lund E; Dumeaux V Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2954-7. PubMed ID: 18990736 [TBL] [Abstract][Full Text] [Related]
15. [Molecular epidemiology in the identification of subjects susceptible to the effects of environmental carcinogens]. Izzotti A; Cartiglia C; De Flora S Ann Ig; 1999; 11(6):439-49. PubMed ID: 10596433 [No Abstract] [Full Text] [Related]
16. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142 [TBL] [Abstract][Full Text] [Related]
17. Integrative epidemiology: from risk assessment to outcome prediction. Spitz MR; Wu X; Mills G J Clin Oncol; 2005 Jan; 23(2):267-75. PubMed ID: 15637390 [TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling: epidemiology meets systems biology. Ulrich CM; Nijhout HF; Reed MC Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):827-9. PubMed ID: 16702357 [No Abstract] [Full Text] [Related]
19. Molecular epidemiology of human cancer: biomarkers of genotoxic exposure and susceptibility. Grant SG J Environ Pathol Toxicol Oncol; 2001; 20(4):245-61. PubMed ID: 11797834 [TBL] [Abstract][Full Text] [Related]
20. Genetic epidemiology of cancer: a multidisciplinary approach. Seminara D; Obrams GI Genet Epidemiol; 1994; 11(3):235-54. PubMed ID: 8088505 [No Abstract] [Full Text] [Related] [Next] [New Search]